[
    {
        "text": "Today’s episode is made in partnership with\nPancOne,",
        "start": 0.0,
        "duration": 2.78
    },
    {
        "text": "an international network of world-class cancer\nresearch institutions",
        "start": 2.79,
        "duration": 3.25
    },
    {
        "text": "looking to increase the survival rate for\nPancreatic Cancer.",
        "start": 6.04,
        "duration": 2.92
    },
    {
        "text": "If you’re interested in learning more or\nare able to donate to their research,",
        "start": 8.96,
        "duration": 3.4
    },
    {
        "text": "head over to www.PancOne.org",
        "start": 12.36,
        "duration": 1.449
    },
    {
        "text": "or click the link in the description.",
        "start": 13.809,
        "duration": 1.331
    },
    {
        "text": "[ intro ]",
        "start": 15.14,
        "duration": 9.899
    },
    {
        "text": "Around the turn of the 21st century,",
        "start": 25.039,
        "duration": 2.061
    },
    {
        "text": "researchers finally found evidence for a hypothesis",
        "start": 27.1,
        "duration": 2.339
    },
    {
        "text": "that had been around for a while:",
        "start": 29.439,
        "duration": 1.481
    },
    {
        "text": "In addition to protecting us from diseases,",
        "start": 30.92,
        "duration": 2.08
    },
    {
        "text": "our immune system helps to protect our body\nfrom itself…",
        "start": 33.0,
        "duration": 2.75
    },
    {
        "text": "by watching out for cancer.",
        "start": 35.75,
        "duration": 1.57
    },
    {
        "text": "And that of course raises the question:",
        "start": 37.32,
        "duration": 2.1
    },
    {
        "text": "Could we give our immune systems a leg up\nin spotting tumors?",
        "start": 39.42,
        "duration": 3.64
    },
    {
        "text": "Could we develop vaccines for cancer?",
        "start": 43.06,
        "duration": 1.92
    },
    {
        "text": "The idea is fairly new,",
        "start": 44.98,
        "duration": 1.15
    },
    {
        "text": "but there are already two cancer vaccines\non the market.",
        "start": 46.13,
        "duration": 2.59
    },
    {
        "text": "And researchers are looking to up that number\nwith a technolog",
        "start": 48.72,
        "duration": 2.25
    },
    {
        "text": "y that promises to be cheaper, faster,",
        "start": 50.97,
        "duration": 2.37
    },
    {
        "text": "and more customizable than traditional approaches:",
        "start": 53.34,
        "duration": 2.7
    },
    {
        "text": "vaccines based on RNA.",
        "start": 56.04,
        "duration": 1.71
    },
    {
        "text": "Traditional vaccines expose our body to antigens:",
        "start": 57.75,
        "duration": 2.77
    },
    {
        "text": "proteins or sugars derived from pathogens\nlike viruses and bacteria,",
        "start": 60.52,
        "duration": 3.55
    },
    {
        "text": "which our immune system can recognize, learn\nfrom,",
        "start": 64.07,
        "duration": 2.85
    },
    {
        "text": "and use to attack a real invader.",
        "start": 66.92,
        "duration": 1.8
    },
    {
        "text": "In cancer vaccines,",
        "start": 68.72,
        "duration": 1.22
    },
    {
        "text": "those antigens come from tumor cells instead,\nbut the idea is the same:",
        "start": 69.94,
        "duration": 3.88
    },
    {
        "text": "We want to train our immune systems to find\nthose antigens",
        "start": 73.82,
        "duration": 2.75
    },
    {
        "text": "and clear out the tumor they were derived\nfrom.",
        "start": 76.57,
        "duration": 2.47
    },
    {
        "text": "One approach is to use whole tumor cells,",
        "start": 79.04,
        "duration": 1.93
    },
    {
        "text": "taken from a patient and modified",
        "start": 80.97,
        "duration": 1.44
    },
    {
        "text": "to serve as training wheels for their immune\nsystem.",
        "start": 82.41,
        "duration": 2.24
    },
    {
        "text": "Others only use the antigens from the patient's\ntumors.",
        "start": 84.65,
        "duration": 2.4
    },
    {
        "text": "But cells and bits of protein aren’t our\nonly options.",
        "start": 87.05,
        "duration": 3.48
    },
    {
        "text": "Enter vaccines based on the genetic code --",
        "start": 90.53,
        "duration": 2.68
    },
    {
        "text": "the nucleic acids DNA and RNA.",
        "start": 93.21,
        "duration": 2.53
    },
    {
        "text": "This approach is meant to be faster and easier",
        "start": 95.74,
        "duration": 2.35
    },
    {
        "text": "than traditional vaccine development.",
        "start": 98.09,
        "duration": 1.68
    },
    {
        "text": "DNA and RNA vaccines reprogram cells to churn\nout that antigen",
        "start": 99.77,
        "duration": 3.1
    },
    {
        "text": "without having to expose our immune system\nto any external proteins or invaders.",
        "start": 102.87,
        "duration": 4.45
    },
    {
        "text": "With DNA vaccines,",
        "start": 107.32,
        "duration": 1.56
    },
    {
        "text": "you make a DNA molecule that carries instructions\nfor the cell to make some antigen,",
        "start": 108.88,
        "duration": 4.32
    },
    {
        "text": "using the same genetic code and protein-making\nmachinery it already runs on.",
        "start": 113.2,
        "duration": 3.68
    },
    {
        "text": "Then, you stick it in the cell's nucleus somehow.",
        "start": 116.88,
        "duration": 1.9
    },
    {
        "text": "After that, the cell copies those instructions\nin the form of a piece of RNA,",
        "start": 118.78,
        "duration": 4.07
    },
    {
        "text": "which travels outside the nucleus to where\nall the proteins are made.",
        "start": 122.85,
        "duration": 3.2
    },
    {
        "text": "And finally, the cell starts pumping out antigens.",
        "start": 126.05,
        "duration": 2.679
    },
    {
        "text": "Meanwhile, with an RNA vaccine,",
        "start": 128.729,
        "duration": 1.801
    },
    {
        "text": "you just skip those first steps",
        "start": 130.53,
        "duration": 1.31
    },
    {
        "text": "and put the instructions on the RNA molecule\nto begin with.",
        "start": 131.84,
        "duration": 2.66
    },
    {
        "text": "The idea is that we can very easily put together\nnucleic acid molecules",
        "start": 134.5,
        "duration": 4.17
    },
    {
        "text": "to code for whatever we like in the lab --",
        "start": 138.67,
        "duration": 2.25
    },
    {
        "text": "not so with proteins or whole tumor cells.",
        "start": 140.92,
        "duration": 2.49
    },
    {
        "text": "So this approach is fast, and it can be tailored\nto whatever we like.",
        "start": 143.41,
        "duration": 3.15
    },
    {
        "text": "There aren’t a huge number of these things\nkicking around yet.",
        "start": 146.56,
        "duration": 2.46
    },
    {
        "text": "While some DNA vaccines are approved for veterinary\nuse,",
        "start": 149.02,
        "duration": 3.25
    },
    {
        "text": "more and more research focuses on RNA instead.",
        "start": 152.27,
        "duration": 2.3
    },
    {
        "text": "And that’s because it’s harder to get\nthe DNA where it needs to be,",
        "start": 154.57,
        "duration": 3.36
    },
    {
        "text": "inside the cell’s nucleus, where it’s\ngoing to be turned into RNA",
        "start": 157.93,
        "duration": 3.139
    },
    {
        "text": "and then sent back out to make the antigen\nwe want.",
        "start": 161.069,
        "duration": 2.131
    },
    {
        "text": "And once the DNA gets there, it can cause\nproblems.",
        "start": 163.2,
        "duration": 2.75
    },
    {
        "text": "Like, sometimes, the cell can incorporate\nloose DNA into its chromosomes,",
        "start": 165.95,
        "duration": 3.97
    },
    {
        "text": "and it’s not picky about where.",
        "start": 169.92,
        "duration": 1.75
    },
    {
        "text": "Rarely, that can interrupt other genetic material\nyou really need --",
        "start": 171.67,
        "duration": 3.63
    },
    {
        "text": "and, ironically, that’s a step toward cancer.",
        "start": 175.3,
        "duration": 3.35
    },
    {
        "text": "Something to avoid in a cancer vaccine.",
        "start": 178.65,
        "duration": 1.72
    },
    {
        "text": "But RNA vaccines skip this step,",
        "start": 180.37,
        "duration": 2.1
    },
    {
        "text": "since they’re a ready-made recipe for a\nprotein antigen we want.",
        "start": 182.47,
        "duration": 2.91
    },
    {
        "text": "And since they’re RNA, there’s no need\nfor them to go into the nucleus to do their",
        "start": 185.38,
        "duration": 3.5
    },
    {
        "text": "thing.",
        "start": 188.88,
        "duration": 1.0
    },
    {
        "text": "Both DNA and RNA vaccines have been studied\nsince the 1990s,",
        "start": 189.88,
        "duration": 3.06
    },
    {
        "text": "and the first RNA cancer vaccine was approved\nfor human trials in 1997.",
        "start": 192.94,
        "duration": 3.59
    },
    {
        "text": "But RNA is actually a pretty delicate molecule.",
        "start": 196.53,
        "duration": 3.25
    },
    {
        "text": "It wasn’t until 2008 that we learned how\nto make the RNA",
        "start": 199.78,
        "duration": 2.45
    },
    {
        "text": "in a vaccine stable enough to easily get it\ninside cells, by chemically modifying some",
        "start": 202.23,
        "duration": 5.03
    },
    {
        "text": "of its components.",
        "start": 207.26,
        "duration": 1.12
    },
    {
        "text": "Since then, RNA vaccine technology has been\nprogressing by leaps and bounds,",
        "start": 208.38,
        "duration": 3.82
    },
    {
        "text": "and a lot of RNA cancer vaccines have already",
        "start": 212.2,
        "duration": 2.13
    },
    {
        "text": "shown promising results in human trials.",
        "start": 214.33,
        "duration": 2.049
    },
    {
        "text": "For example,",
        "start": 216.379,
        "duration": 1.0
    },
    {
        "text": "in a small early clinical trial of an RNA\ncancer vaccine in Germany",
        "start": 217.379,
        "duration": 2.83
    },
    {
        "text": "conducted on 13 melanoma patients,",
        "start": 220.209,
        "duration": 2.331
    },
    {
        "text": "there was an immune response against the cancer\nin all of them.",
        "start": 222.54,
        "duration": 2.79
    },
    {
        "text": "And in two of the patients, the vaccine shrunk\ntheir tumors.",
        "start": 225.33,
        "duration": 2.87
    },
    {
        "text": "And another clinical test of an RNA melanoma\nvaccine, developed in Belgium, showed significant",
        "start": 228.2,
        "duration": 4.86
    },
    {
        "text": "tumor reduction in 15 out of the 39 patients\nin a more advanced trial.",
        "start": 233.06,
        "duration": 4.12
    },
    {
        "text": "Which means these two, and maybe others, could\nbe coming to a hospital near you.",
        "start": 237.18,
        "duration": 3.72
    },
    {
        "text": "But if they’re so great, why aren’t RNA\nvaccines everywhere already?",
        "start": 240.9,
        "duration": 3.369
    },
    {
        "text": "Well, any vaccine can be set back in clinical\ntrials by safety issues or side effects.",
        "start": 244.269,
        "duration": 4.911
    },
    {
        "text": "But cancer vaccines face some potential additional\nsnags.",
        "start": 249.18,
        "duration": 3.05
    },
    {
        "text": "It’s often pointed out that “cancer”\nisn’t really one disease, and that’s true.",
        "start": 252.23,
        "duration": 4.069
    },
    {
        "text": "Which means you can’t design one vaccine,\nor half a dozen.",
        "start": 256.299,
        "duration": 2.52
    },
    {
        "text": "In fact, any given vaccine is likely to be\neffective only in patients with very specific",
        "start": 258.819,
        "duration": 5.0
    },
    {
        "text": "cancers --",
        "start": 263.819,
        "duration": 1.0
    },
    {
        "text": "because every type is likely to have different\nantigens.",
        "start": 264.819,
        "duration": 2.5
    },
    {
        "text": "So you need your clinical trial participants\nto have that exact cancer.",
        "start": 267.319,
        "duration": 3.77
    },
    {
        "text": "Say, not just melanoma, but melanoma of the\neye,",
        "start": 271.089,
        "duration": 3.571
    },
    {
        "text": "which only happens in one out of ten thousand\npeople.",
        "start": 274.66,
        "duration": 2.099
    },
    {
        "text": "And on top of that, there are other factors\nthat may exclude candidates from the trial,",
        "start": 276.759,
        "duration": 3.74
    },
    {
        "text": "like having serious conditions other than\ncancer that could complicate the results.",
        "start": 280.499,
        "duration": 3.88
    },
    {
        "text": "So that makes cancer vaccine trials extremely\nhard to recruit for,",
        "start": 284.379,
        "duration": 3.461
    },
    {
        "text": "and it also means that each phase of the clinical\ntrials",
        "start": 287.84,
        "duration": 2.87
    },
    {
        "text": "takes an extra long time to complete.",
        "start": 290.71,
        "duration": 1.94
    },
    {
        "text": "When you look at it that way, we’ve actually\nmade",
        "start": 292.65,
        "duration": 2.31
    },
    {
        "text": "pretty good progress since the late 2000s.",
        "start": 294.96,
        "duration": 1.83
    },
    {
        "text": "But what makes things even more difficult",
        "start": 296.79,
        "duration": 2.26
    },
    {
        "text": "are all the ways tumors deflect our immune\nsystem.",
        "start": 299.05,
        "duration": 2.869
    },
    {
        "text": "To prevent our immune system from attacking\nhealthy cells,",
        "start": 301.919,
        "duration": 2.96
    },
    {
        "text": "every cell in our body has self-antigens that\ntell patrolling immune cells “hey, all good,",
        "start": 304.879,
        "duration": 4.481
    },
    {
        "text": "I super definitely belong here and you shouldn’t\nmurder me.”",
        "start": 309.36,
        "duration": 3.269
    },
    {
        "text": "But for most cancer vaccines, that safety\nfeature is actually a problem.",
        "start": 312.629,
        "duration": 3.41
    },
    {
        "text": "You see, a lot of the antigens that tumor\ncells",
        "start": 316.039,
        "duration": 2.25
    },
    {
        "text": "make are actually your body’s own self-antigens.",
        "start": 318.289,
        "duration": 3.63
    },
    {
        "text": "That makes sense, because those are the antigens\nthey have the genes to make.",
        "start": 321.919,
        "duration": 3.411
    },
    {
        "text": "Sure, tumor genetics get a bit hinky,",
        "start": 325.33,
        "duration": 2.03
    },
    {
        "text": "so they might make weird self-antigens.",
        "start": 327.36,
        "duration": 1.899
    },
    {
        "text": "Like, making a lot of the kind of antigens\nthat you mostly only make as a fetus.",
        "start": 329.259,
        "duration": 4.511
    },
    {
        "text": "But those antigens are still proteins that\nmark the tumor cells as “one of us,”",
        "start": 333.77,
        "duration": 4.47
    },
    {
        "text": "so vaccines based on them have a friendly-fire\nproblem.",
        "start": 338.24,
        "duration": 2.919
    },
    {
        "text": "They can end up damaging healthy tissues as\nwell.",
        "start": 341.159,
        "duration": 2.201
    },
    {
        "text": "So any vaccine, no matter how futuristic,",
        "start": 343.36,
        "duration": 2.85
    },
    {
        "text": "still needs to find antigens that are specific\nto the tumor, so it doesn’t end up hurting",
        "start": 346.21,
        "duration": 4.379
    },
    {
        "text": "our body.",
        "start": 350.589,
        "duration": 1.0
    },
    {
        "text": "That’s a tall order.",
        "start": 351.589,
        "duration": 1.0
    },
    {
        "text": "But it’s not impossible.",
        "start": 352.589,
        "duration": 1.35
    },
    {
        "text": "And that’s thanks to huge progress in genetic\nsequencing.",
        "start": 353.939,
        "duration": 2.51
    },
    {
        "text": "The first cancer genome was only sequenced\nin 2008.",
        "start": 356.449,
        "duration": 3.261
    },
    {
        "text": "But since then, researchers have identified\na bunch of mutated,",
        "start": 359.71,
        "duration": 3.12
    },
    {
        "text": "novel antigens that tumors make.",
        "start": 362.83,
        "duration": 1.769
    },
    {
        "text": "There’s a hitch, though.",
        "start": 364.599,
        "duration": 1.0
    },
    {
        "text": "It turns out that most of these new antigens\nare unique in every single patient.",
        "start": 365.599,
        "duration": 4.57
    },
    {
        "text": "And every tumor makes a bunch of them,",
        "start": 370.169,
        "duration": 2.31
    },
    {
        "text": "so to make sure the vaccine will do its job,",
        "start": 372.479,
        "duration": 1.96
    },
    {
        "text": "you better be ready to hit as many as possible.",
        "start": 374.439,
        "duration": 2.72
    },
    {
        "text": "And here is where RNA vaccines really shine.",
        "start": 377.159,
        "duration": 3.19
    },
    {
        "text": "See, you can cook up a personalized cancer\nvaccine using other technologies,",
        "start": 380.349,
        "duration": 5.081
    },
    {
        "text": "but that is way more expensive and time-consuming.",
        "start": 385.43,
        "duration": 1.88
    },
    {
        "text": "Thanks to new, faster sequencing techniques,",
        "start": 387.31,
        "duration": 3.49
    },
    {
        "text": "scientists can quickly identify all of a tumor’s\nunique mutations,",
        "start": 390.8,
        "duration": 3.47
    },
    {
        "text": "and then use powerful predictive algorithms\nto figure out which ones it would be best",
        "start": 394.27,
        "duration": 4.009
    },
    {
        "text": "to target.",
        "start": 398.279,
        "duration": 1.0
    },
    {
        "text": "Unlike in typical vaccine design, they don’t\nneed a lot of tumor cells to do that,",
        "start": 399.279,
        "duration": 4.14
    },
    {
        "text": "which is a good thing because obtaining enough\nof those can be hard in certain types of cancer.",
        "start": 403.419,
        "duration": 3.62
    },
    {
        "text": "And once you have the gear in place to make\nRNA vaccines,",
        "start": 407.039,
        "duration": 2.791
    },
    {
        "text": "creating a new one is just a matter of plugging\nin that new genetic blueprint",
        "start": 409.83,
        "duration": 3.78
    },
    {
        "text": "for the tumor antigens you found.",
        "start": 413.61,
        "duration": 1.529
    },
    {
        "text": "Plus, it’s super easy to pack all of them\ninto a single RNA shot.",
        "start": 415.139,
        "duration": 4.56
    },
    {
        "text": "So by using RNA, scientists can design a vaccine\nin a matter of hours,",
        "start": 419.699,
        "duration": 4.64
    },
    {
        "text": "something that takes months for traditional\nvaccines.",
        "start": 424.339,
        "duration": 2.05
    },
    {
        "text": "And this makes a whole lot of difference,",
        "start": 426.389,
        "duration": 1.65
    },
    {
        "text": "because patients who are getting these experimental\ncancer vaccines",
        "start": 428.039,
        "duration": 2.77
    },
    {
        "text": "have often exhausted other treatment options,",
        "start": 430.809,
        "duration": 2.901
    },
    {
        "text": "so every minute counts.",
        "start": 433.71,
        "duration": 1.319
    },
    {
        "text": "But there’s one last hurdle.",
        "start": 435.029,
        "duration": 2.2
    },
    {
        "text": "Even if you know how to tell tumor cells and\nhealthy cells apart,",
        "start": 437.229,
        "duration": 2.69
    },
    {
        "text": "you still need to overcome all the ways that\ntumors defend themselves",
        "start": 439.919,
        "duration": 3.601
    },
    {
        "text": "from our immune system.",
        "start": 443.52,
        "duration": 1.509
    },
    {
        "text": "Because our immune system does normally counter\nthem --",
        "start": 445.029,
        "duration": 2.301
    },
    {
        "text": "so tumors have to find ways around it.",
        "start": 447.33,
        "duration": 2.299
    },
    {
        "text": "First of all, they’re built in such a way\nthat it’s hard for immune cells to physically",
        "start": 449.629,
        "duration": 3.19
    },
    {
        "text": "get inside.",
        "start": 452.819,
        "duration": 1.0
    },
    {
        "text": "Even if they do manage to weasel their way\nin,",
        "start": 453.819,
        "duration": 1.951
    },
    {
        "text": "the tumor floods them with chemicals to switch\nthem off --",
        "start": 455.77,
        "duration": 2.929
    },
    {
        "text": "or force them to deactivate other immune cells\nas they come in!",
        "start": 458.699,
        "duration": 2.86
    },
    {
        "text": "To help them break through a tumor’s immune\nsuppression,",
        "start": 461.559,
        "duration": 2.58
    },
    {
        "text": "cancer vaccines are often combined with things\nthat boost the immune response.",
        "start": 464.139,
        "duration": 3.791
    },
    {
        "text": "Like immune checkpoint inhibitors,",
        "start": 467.93,
        "duration": 1.78
    },
    {
        "text": "which are medications that mess with the ways\ntumors put our immune cells to sleep.",
        "start": 469.71,
        "duration": 3.509
    },
    {
        "text": "You can also induce a little bit of inflammation,",
        "start": 473.219,
        "duration": 2.44
    },
    {
        "text": "which calls in immune cells that can pick\nup the antigen",
        "start": 475.659,
        "duration": 2.38
    },
    {
        "text": "and teach immune cells what their target is.",
        "start": 478.039,
        "duration": 2.25
    },
    {
        "text": "And this is where RNA vaccines have another\nadvantage.",
        "start": 480.289,
        "duration": 2.821
    },
    {
        "text": "Foreign RNA is naturally recognized by our\nimmune system",
        "start": 483.11,
        "duration": 3.199
    },
    {
        "text": "as the traces of a potential virus attack,",
        "start": 486.309,
        "duration": 2.78
    },
    {
        "text": "because many viruses have genomes made of\nRNA rather than DNA.",
        "start": 489.089,
        "duration": 3.37
    },
    {
        "text": "Initially, this was a problem for RNA vaccines,",
        "start": 492.459,
        "duration": 2.54
    },
    {
        "text": "because it got researchers worried about serious\nside effects from the inflammation.",
        "start": 494.999,
        "duration": 3.29
    },
    {
        "text": "But in a classic example of turning a bug\ninto a feature,",
        "start": 498.289,
        "duration": 3.731
    },
    {
        "text": "scientists realized they could balance that\nimmune response",
        "start": 502.02,
        "duration": 2.47
    },
    {
        "text": "so it worked to the vaccine’s advantage.",
        "start": 504.49,
        "duration": 1.849
    },
    {
        "text": "And that makes RNA cancer vaccines even easier\nto make,",
        "start": 506.339,
        "duration": 3.76
    },
    {
        "text": "because their very nature will help draw in\nthe immune system.",
        "start": 510.099,
        "duration": 3.421
    },
    {
        "text": "Even though the technology is so new,",
        "start": 513.52,
        "duration": 1.68
    },
    {
        "text": "an RNA cancer vaccine has already entered\nPhase III human trials --",
        "start": 515.2,
        "duration": 3.79
    },
    {
        "text": "the last step before approval.",
        "start": 518.99,
        "duration": 1.77
    },
    {
        "text": "This vaccine is meant to target uveal melanoma,",
        "start": 520.76,
        "duration": 2.55
    },
    {
        "text": "or melanoma of the eye, using the patient's\ntumors' unique antigens.",
        "start": 523.31,
        "duration": 4.49
    },
    {
        "text": "It's currently being tested on 200 volunteers\nin Germany,",
        "start": 527.8,
        "duration": 2.78
    },
    {
        "text": "and the trial is scheduled to complete in\n2023.",
        "start": 530.58,
        "duration": 3.22
    },
    {
        "text": "Scientists are also experimenting with multiple\nways to improve the potency of RNA vaccines,",
        "start": 533.8,
        "duration": 4.67
    },
    {
        "text": "like by making the RNA self-replicate",
        "start": 538.47,
        "duration": 1.91
    },
    {
        "text": "to cook up even more precious antigens for\nour immune system.",
        "start": 540.38,
        "duration": 3.18
    },
    {
        "text": "All of this progress shows that we’re getting\ncloser to an era of medicine",
        "start": 543.56,
        "duration": 3.07
    },
    {
        "text": "where we can direct our own cells to make\nany protein our immune system needs.",
        "start": 546.63,
        "duration": 4.36
    },
    {
        "text": "And even though the results we have so far\nare limited,",
        "start": 550.99,
        "duration": 2.7
    },
    {
        "text": "RNA-based cancer vaccines may just be right\naround the corner.",
        "start": 553.69,
        "duration": 3.51
    },
    {
        "text": "And that could mean treatments for not just\nmelanoma, but all sorts of cancers --",
        "start": 557.2,
        "duration": 3.56
    },
    {
        "text": "potentially including pancreatic cancer.",
        "start": 560.76,
        "duration": 2.54
    },
    {
        "text": "As we mentioned earlier,",
        "start": 563.3,
        "duration": 1.14
    },
    {
        "text": "this episode is made in partnership with the\nPancOne Research Network.",
        "start": 564.44,
        "duration": 2.89
    },
    {
        "text": "They’re composed of institutions like John\nHopkins Medicine,",
        "start": 567.33,
        "duration": 2.86
    },
    {
        "text": "Memorial Sloan Kettering Cancer Center and\nthe Dana-Farber Institute.",
        "start": 570.19,
        "duration": 3.5
    },
    {
        "text": "And they’re hoping to raise $200,000 to\nbetter understand pancreatic cancer,",
        "start": 573.69,
        "duration": 4.31
    },
    {
        "text": "accelerate diagnosis, explore new treatment\noptions, and ultimately save more lives.",
        "start": 578.0,
        "duration": 4.53
    },
    {
        "text": "In 2018, there were more than 450,000 new\ncases of pancreatic cancer, and on average,",
        "start": 582.53,
        "duration": 5.4
    },
    {
        "text": "this cancer has only a 5-10% five-year survival\nrate --",
        "start": 587.93,
        "duration": 3.45
    },
    {
        "text": "the lowest survival rate of all cancers.",
        "start": 591.38,
        "duration": 2.49
    },
    {
        "text": "And that's barely changed in 40 years.",
        "start": 593.87,
        "duration": 1.83
    },
    {
        "text": "So, this is a big project, and their goal\nto raise the survival rate to 14%.",
        "start": 595.7,
        "duration": 4.44
    },
    {
        "text": "If you want to learn more about what PancOne\nis doing or are able to donate to their research,",
        "start": 600.14,
        "duration": 3.69
    },
    {
        "text": "you can find more at www.PancOne.org or click\nthe link in description.",
        "start": 603.83,
        "duration": 3.35
    },
    {
        "text": "We’ve contributed and, if you’re able,\nhope you’ll consider it, too!",
        "start": 607.18,
        "duration": 10.33
    },
    {
        "text": "[ outro ]",
        "start": 617.51,
        "duration": 1.24
    }
]